Results 111 to 120 of about 33,479 (238)

Efficacy and Safety of Co‐Ablation Combined With Aintilimab for Metastatic Melanoma to the Liver (CryoCheck‐001): A Phase II Trial

MedComm, Volume 7, Issue 10, October 2026.
Liver metastasis is a key driver of immune tolerance in patients with melanoma receiving immune checkpoint inhibitor therapy. This single‐arm phase II trial prospectively investigated the efficacy and safety of co‐ablation combined with sintilimab for liver metastatic melanoma.
Lujun Shen, Letao Lin, Shuanggang Chen, Chen Li, Ruizhi Tang, Lin Xie, Yujia Wang, Yunpeng Li, Hongliang Zou, Dandan Li, Xiaoshi Zhang, Weijun Fan   +11 more
wiley   +1 more source

A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma

, 2015
Purpose: To compare doxorubicin-loaded HepaSphere transarterial chemoembolization versus conventional transarterial chemoembolization in terms of survival, time to recurrence, acute reversible hepatotoxicity, postembolization syndrome, and ...
KÜÇÜKAY, FAHRETTİN, Bostanci, Erdal B., Ozdemir, Mustafa, Badem, Serife, Akdogan, Meral, Ozbulbul, Nilgun I., KÜÇÜKAY, MURAT BÜLENT, Karan, Adnan, Okten, Riza S., Unlu, Ipek   +9 more
core   +1 more source

Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review

Current Therapeutic Research, 2017
Background: The Ebola virus has been responsible for numerous outbreaks since the 1970s, with the most recent outbreak taking place between 2014 and 2016 and causing an international public health emergency. Ebola virus disease (EVD) has a high mortality
Hussein Sweiti, MD, MSc, FACS, Obinna Ekwunife, MSc, PhD, Thomas Jaschinski, MHE, Stefan K. Lhachimi, MPP, MSc, PhD   +3 more
doaj   +1 more source

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

, 2015
Ji Hye Jang, Jin-Woo Lee, Ji Taek Hong, Young-Joo JinDivision of Gastroenterology and Hepatology, Inha University School of Medicine and Hospital, Incheon, Republic of Korea Abstract: Transarterial chemoembolization (TACE) is the standard treatment for ...
Hong JT, Jin YJ, Jang JH, Lee JW
core  

Transcatheter Arterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Background/Aims: In this study, we evaluated the efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with hepatic arterial infusion chemotherapy (HAIC) compared to TACE monotherapy for the treatment of unresectable ...
Yi Feng, Zuxiang Peng, Zhengyan Li, Hanchen Wang, Guoying Feng, Yongliang Tang, Hongming Liu, Shu Yao, Xun Huang, Wen Tang   +9 more
core   +1 more source

Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma [PDF]

, 2008
Background: Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths. Difficulties to diagnose HCC at early stages remain the major obstacle to curative (surgical) therapy. Therapy in advanced stages has to be considered palliative.
Forstpointner, Roswitha, Naujoks, Kurt, Lenz, Georg, Schalhorn, Andreas, Bartelheim, Kerstin, Christopeit, Maximilian, Kuehnbach, Robert   +6 more
core   +1 more source

Modified Patent Hemostasis Strategy Based on the Platelet Counts for Transradial Access Chemoembolization in Patients with Hepatocellular Carcinoma: A Prospective Single-Center Study

Journal of Hepatocellular Carcinoma, 2023
Yin-Gen Luo, Xiao-Wu Zhang, Jiay-Wei Tsauo, Ying Li, Jin-Gui Li, Qing Peng, Ya-Wei Li, Wei Sun, He Zhao, Xiao Li Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of
Luo YG, Zhang XW, Tsauo JW, Li Y, Li JG, Peng Q, Li YW, Sun W, Zhao H, Li X   +9 more
doaj  

Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)

, 2018
Yanyan Wei,* Feng Dai,* Tianhui Zhao, Chen Tao, Lili Wang, Wei Ye, Wei Zhao Liver Disease Department, The Second Hospital of Nanjing, Medical School of Southeast University, Nanjing, China *These authors contributed equally to this work Background: The ...
Tao C, Zhao W, Dai F, Ye W, Zhao T, Wei Y, Wang L   +6 more
core  

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma

Drug Design, Development and Therapy, 2020
Sung-Hua Chiu,1 Ping-Ying Chang,2 Yu-Lueng Shih,3 Wen-Yen Huang,4 Kai-Hsiung Ko,1 Wei-Chou Chang,1 Guo-Shu Huang1 1Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; 2Division of Hematology/Oncology ...
Chiu SH, Chang PY, Shih YL, Huang WY, Ko KH, Chang WC, Huang GS   +6 more
doaj  

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

, 2017
Waleed Fateen,1,2 Farooq Khan,1 Richard J O’Neill,3 Martin W James,1 Stephen D Ryder,1 Guruprasad P Aithal1,2 1NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, 2Nottingham Digestive
James MW, Khan F, Fateen W, O’Neill RJ, Aithal GP, Ryder SD   +5 more
core